TrkB Agonist Antibody Pretreatment Enhances Neuronal Survival and Long-Term Sensory Motor Function Following Hypoxic Ischemic Injury in Neonatal Rats
Open accessThe DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Abstract
Perinatal hypoxic ischemia (H-I) causes brain damage and long-term neurological impairments, leading to motor dysfunctions and cerebral palsy. Many studies have demonstrated that the TrkB-ERK1/2 signaling pathway plays a key role in mediating the protective effect of brain-derived neurotrophic factor (BDNF) following perinatal H-I brain injury in experimental animals. In the present study, we explored the neuroprotective effects of the TrkB-specific agonist monoclonal antibody 29D7 on H-I brain injury in neonatal rats. First, we found that intracerebroventricular (icv) administration of 29D7 in normal P7 rats markedly increased the levels of phosphorylated ERK1/2 and phosphorylated AKT in neurons up to 24 h. Second, P7 rats received icv administration of 29D7 and subjected to H-I injury induced by unilateral carotid artery ligation and exposure to hypoxia (8% oxygen). We found that 29D7, to a similar extent to BDNF, significantly inhibited activation of caspase-3, a biochemical hallmark of apoptosis, following H-I injury. Third, we found that this 29D7-mediated neuroprotective action persisted at least up to 5 weeks post-H-I injury as assessed by brain tissue loss, implicating long-term neurotrophic effects rather than an acute delay of cell death. Moreover, the long-term neuroprotective effect of 29D7 was tightly correlated with sensorimotor functional recovery as assessed by a tape-removal test, while 29D7 did not significantly improve rotarod performance. Taken together, these findings demonstrate that pretreatment with the TrkB-selective agonist 29D7 significantly increases neuronal survival and behavioral recovery following neonatal hypoxic-ischemic brain injury.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“TDP6 and 29D7 have been shown to represent other promising BDNF mimetic molecules able to promote oligodendrocyte-mediated myelination in vitro (Wong et al. 2014) and to enhance neuronal survival and neurotic outgrowth in vitro and in vivo as well as to provide long-lasting neuroprotection against neonatal hypoxic-ischemic brain injury (Kim et al. 2014; Qian et al. 2006).”
From Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression (2018) · cites this paper as Kim et al. 2014
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ischemic Cell Death in Brain Neurons
Lipton, P. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.4.1431 · Cited by 3,043 · cited 1×
“Several key molecular and cellular processes responsible for ischemia-induced neuronal death have been identified in mature and developing brains, among which are glutamate and nitric oxide neurotoxicity, calcium accumulation, caspase activation and inflammatory activation [1,2,3,4,5].”
BackgroundRegulation of neuronal survival by the serine-threonine protein kinase Akt
Dudek, H., Datta, S. R., Franke, T. F., Birnbaum, M. J., Yao, R., Cooper, G. M., Segal, R. A., Kaplan, D. R., & Greenberg, M. E. (1997) · Science · doi:10.1126/science.275.5300.661 · Cited by 2,436
The influence of immaturity on hypoxic‐ischemic brain damage in the rat
Rice, J. E., Vannucci, R. C., & Brierley, J. B. (1981) · Annals of Neurology · doi:10.1002/ana.410090206 · Cited by 2,134 · cited 2×
“The neonatal H-I brain injury model was performed as previously described [35,36,37,38] with modifications.”
MethodThe Science of Stroke: Mechanisms in Search of Treatments
Moskowitz, M. A., Lo, E. H., & Iadecola, C. (2010) · Neuron · doi:10.1016/j.neuron.2010.07.002 · Cited by 1,930
Bonni, A., Brunet, A., West, A. E., Datta, S. R., Takasu, M. A., & Greenberg, M. E. (1999) · Science · doi:10.1126/science.286.5443.1358 · Cited by 1,901 · cited 2×
“Cell survival-promoting effects of neurotrophins, in particular BDNF, are elicited by activation of different intracellular signaling cascades including the phosphatidylinositol 3-kinase (PI3-K) and AKT, and the extracellular signal-related kinase1/2 (ERK1/2) pathways [48,53,54].”
BackgroundBDNF function in adult synaptic plasticity: The synaptic consolidation hypothesis
Bramham, C. R., & Messaoudi, E. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.06.003 · Cited by 1,193 · cited 1×
“Brain-derived neurotrophic factor (BDNF), the endogenous agonist for the tropomyosin-related kinase B (TrkB), has been shown to exert strong survival and neuroprotective effects in the central nervous system (CNS) and to facilitate post-injury recovery and activity-dependent synaptic plasticity [12,13,14,15,16].”
BackgroundHuman marrow stromal cell therapy for stroke in rat: Neurotrophins and functional recovery
Li, Y., Chen, J., Chen, X. G., Wang, L., Gautam, S. C., Xu, Y. X., Katakowski, M., Zhang, L. J., Lu, M., Janakiraman, N., et al. (2002) · Neurology · doi:10.1212/wnl.59.4.514 · Cited by 869 · cited 1×
“Brain tissues were prepared as described previously [36,42,43] and subjected to immunofluorescent labeling.”
MethodRole of matrix metalloproteinases in delayed cortical responses after stroke
Zhao, B.-Q., Wang, S., Kim, H.-Y., Storrie, H., Rosen, B. R., Mooney, D. J., Wang, X., & Lo, E. H. (2006) · Nature Medicine · doi:10.1038/nm1387 · Cited by 702 · cited 3×
“We next sought to explore if 29D7-mediated neuroprotection was associated with long-term behavioral improvements by employing the sticky tape-removal method, a widely used test of somatosensory function in rodents [44,45].”
BackgroundMethodAnoxic-ischemic encephalopathy in rats.
LEVINE, S. (1960) · PubMed · Cited by 634
trkB, a novel tyrosine protein kinase receptor expressed during mouse neural development.
Klein, R., Parada, L. F., Coulier, F., & Barbacid, M. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08545.x · Cited by 598 · cited 1×
“Based on the fact that TrkB is expressed in neurons in the brain [49,50], we hypothesized that activation of ERK1/2 and AKT by 29D7 may primarily occur in neurons.”
Background
Research works printed but not linked: 1
- Paxinos G, Watson C (2005) The rat brain in sterotaxic coordinates. Elsevier Academic Press.
Cited by
Neonatal Hypoxia Ischaemia: Mechanisms, Models, and Therapeutic Challenges
Millar, L. J., Shi, L., Hoerder-Suabedissen, A., & Molnár, Z. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00078 · Cited by 348
“, 2015); impaired motor function as assessed by rotarod test, open field and motor reflexes (Barth and Stanfield, 1990; Jansen and Low, 1996a,b; Jansen et al., 1997; Balduini et al., 2000, 2001; Tomimatsu et al., 2002; Ådén et al., 2003; Lubics et al., 2005; Pazaiti et al., 2009; Im et al., 2010; Nijboer et al., 2010;…”
BackgroundNeurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression
Levy, M. J. F., Boulle, F., Steinbusch, H. W., van den Hove, D. L. A., Kenis, G., & Lanfumey, L. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4950-4 · Cited by 308
Targeting synapse function and loss for treatment of neurodegenerative diseases
Dejanovic, B., Sheng, M., & Hanson, J. E. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00823-1 · Cited by 193
“…survival in the spinal-root avulsion model in vivo 120 , protect against neuronal injury in animal models of perinatal hypoxic ischaemia and stroke 121,122 , improve the survival of retinal ganglion cells following optic nerve axotomy or elevated ocular pressure 117 , and promote plasticity and…”
Brain-Derived Neurotrophic Factor and Its Potential Therapeutic Role in Stroke Comorbidities
Liu, W., Wang, X., O’Connor, M., Wang, G., & Han, F. (2020) · Neural Plasticity · doi:10.1155/2020/1969482 · Cited by 160
“Recent studies suggest that TrkB agonistic antibodies bind to the receptor with high specificity and affinity to activate its downstream signaling cascades; thus, they exhibit protective effects in ischemic stroke [10, 117], HD [118], and glaucoma [119] and regulate energy metabolism [120].”
BackgroundHing, B., Sathyaputri, L., & Potash, J. B. (2018) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32616 · Cited by 137
“Impairment of these processes can affect cognition and behavior (Costa et al., 2012; Dalla, Bangasser, Edgecomb,& Shors, 2007; Kim et al., 2014;Nutan&Meti, 2000; Sakata, Jin, & Jha, 2010) (Table 1).”
Background
Metadata
- Authors
- Kim, G. S., Cho, S., Nelson, J. W., Zipfel, G. J., & Han, B. H.
- Affiliations
- Seoul National University (KR)
- Washington University in St. Louis (US)
- Corresponding author
- Han, Byung Hee
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-02-14
- Volume
- 9
- Issue
- 2
- Pages
- e88962
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3925177
- OpenAlex
- W2036514880
- Cited by
- 27
- References
- 68
- Citations by year
- 2026: 1 · 2023: 5 · 2022: 1 · 2021: 1 · 2020: 4 · 2019: 2 · 2018: 3 · 2017: 3 · 2016: 4 · 2015: 1 · 2014: 2
- FWCI
- 3.14
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Digital Commons@Becker (Washington University School of Medicine) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Washington University in St. Louis
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal and fetal brain pathology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury and Neurovascular Disturbances
- Keywords
- perinatal hypoxic-ischemic brain injury, neuroprotection, brain-derived neurotrophic factor, ERK signaling, Akt phosphorylation, caspase-3, neuronal apoptosis, sensorimotor recovery, cerebral palsy, neonatal rats
- MeSH terms
- Animals, Animals, Newborn, Antibodies, Body Temperature, Cell Survival, Enzyme Activation, Female, Injections, Intraventricular, Male, Motor Activity, Phosphorylation, Sensory Receptor Cells, Rats, Sprague-Dawley, Neuroprotective Agents, Receptor, trkB, Hypoxia-Ischemia, Brain, Extracellular Signal-Regulated MAP Kinases, Proto-Oncogene Proteins c-akt, Rats, Caspase 3
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: TrkB Agonist Antibody Pretreatment Enhances Neuronal Survival and Long-Term Sensory Motor Function Following Hypoxic Ischemic Injury in Neonatal Rats. https://app.cochat.ai/papers/10.1371/journal.pone.0088962
- The paper
- Kim, G. S., Cho, S., Nelson, J. W., Zipfel, G. J., & Han, B. H. (2014). TrkB Agonist Antibody Pretreatment Enhances Neuronal Survival and Long-Term Sensory Motor Function Following Hypoxic Ischemic Injury in Neonatal Rats. PLoS ONE. https://doi.org/10.1371/journal.pone.0088962
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.